Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs
TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) ("Reunion" or the Company), a biopharmaceutical company committed to developing innovative therapeutic solutions for underserved mental health conditions, announced today that it has appointed Edward Smith as the Companys Chief Financial Officer and Aviva Asnis-Alibozek as Vice President, Medical Affairs, effective immediately.
- TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) ("Reunion" or the Company), a biopharmaceutical company committed to developing innovative therapeutic solutions for underserved mental health conditions, announced today that it has appointed Edward Smith as the Companys Chief Financial Officer and Aviva Asnis-Alibozek as Vice President, Medical Affairs, effective immediately.
- Dr. Asnis-Alibozek earned her Doctor of Medical Science degree in the advanced professional practice of administrative medicine from the University of Lynchburg.
- Edward Smith succeeds Donna Wong who has resigned as Chief Financial Officer.
- To be added to the Reunion Neuroscience email list, please email [email protected] with REUN in the subject line.